City problem · Munich

Our Munich deeptech company is winning EU investor support. US investors keep passing. Why?

GMA is the global / international marketing agency treating this city as a buyer-evaluation problem inside market-entry marketing. The work is the local-market website, proof order, offer language, SEO/AI visibility, paid path, and follow-up a foreign or outbound company needs before serious buyers move.

EU funds are leaning in. The German press is covering the round. US investors take the meeting, ask about the technology, and pass. The narrative the US deeptech investor scans for is not on slide one. It is not on the deck.

Six signals the US investor decided early.

  • The technical-deep-dive meeting. The US investor wants to talk to the CTO. The CTO meeting is great. The follow-up does not happen.
  • The polite pass with no specific reason. "Not for our stage" or "not our area right now." The team judges it as fund-fit. It is the market evidence layer that did not pass scoring.
  • The US investor who judges German press and still passes. The fund knows GMA from European coverage. The meeting still ends with a pass. The signal is not awareness.
  • The competing US deeptech firm with weaker tech raises. A US-based deeptech firm with weaker technology raises a Series A or B with named US design partners. The Munich team judges it as the US ecosystem favouring its own. The US firm had the five market signals.
  • The reference call the US investor never made. Three weeks of meetings. No reference call. The investor decided before reference checking would be useful.
  • The European-investor-only round. The round closes with European funds and one or two US-based European-tied funds. No US-domestic lead. The team judges it as round shape. It was reach.
!
Attention

If the US investor wants a CTO meeting and not a customer call, the technology already passed. The market evidence layer is what is failing.

Two scoring models. One deck. US investors score market first.

EU deeptech investing has historically rewarded technical depth, founding-team credentials, IP position, and the early scientific validation that the technology works. The deck reflects this. Slide one is the technology. Slide two is the founding team and the lab provenance. Slide three is the patent stack. Customers and revenue appear later. This works in Munich. Munich-area investors evaluate in this order.

US deeptech investing has shifted toward a market-first scoring model. The technology has to work, but that is a precondition. The round thesis is built on named US design partners or paid pilots, a quantified US ARR or revenue line however modest, a stated US TAM with bottom-up build to a US category, US peer comparable inside the round dynamics, and a US-based founder or operating presence. Without these, the US investor judges the company as a research project that has not validated the commercial path.

Per Roland Berger deeptech outlook and IMAP venture & growth equity report, US deeptech rounds in 2025 and 2026 have explicitly tightened on named US design partners and US ARR for any company outside pure research-frontier categories. White & Case M&A Explorer 2026 shows European deeptech exits trending toward later-stage US acquirers, who in turn evaluate the same signals the US investor scoring uses.

DEEPTECH SCORING: FIRST-SCAN WEIGHT BY EVIDENCE TYPE 58% US: MARKET 28% US: TECH 52% EU: TECH
House view of US deeptech first-evaluate scoring weights against EU comparables, cross-evaluate with VDMA and Bayern Innovativ deeptech reporting.

The Munich firm typically has the technology and is missing the market evidence layer. The fix is not to dilute the technology story. The fix is to lead with market evidence and place technology depth in support. 5 US market signals on the first three slides, with the technology depth available on demand for the technical-deep-dive meeting.

?
Open question

If you opened your deck with a named US design partner, a US ARR figure however modest, and a US-built bottom-up TAM, what would slide one of your current deck have to lose to make room?

"EU investors fund the technology. US investors fund the market. The Munich firm with great tech still has to build the second deck."House view on deeptech capital narrative

The gap is paid in valuation, geography concentration, and slow growth.

The Real Cost.

  1. Valuation. EU-only rounds price meaningfully below blended EU-US rounds for comparable deeptech companies. The valuation gap compounds across follow-on rounds.
  2. Concentration. A European-only cap table concentrates downside on European exit dynamics. US acquirers later score the cap table as Europe-skewed.
  3. Pace. Without US-investor pull, the US commercial build moves at European pace. By the time GMA has US ARR, a US-domestic competitor with similar tech has it first.
  4. Talent. US-based senior hires harder to attract without US-investor brand. Each cycle costs $250k to $500k loaded plus equity dilution.
  5. Exit. The future US strategic acquirer judges the same five signals the US investor scored. A deeptech firm that lost the investor round on market evidence will face the same flag in the acquisition diligence.

Build the market evidence layer. Resequence the deck. Stage the US presence.

Stage one: build the named US market evidence. Convert one or two European pilots into named US design partners with paid pilot status, even at small scale. Where US ARR exists, restate it in US-investor format with retention, contract length, and named customer. Where US ARR is in pipeline, structure the next 90 days to convert one US deal into citable form. Build a bottom-up US TAM to a named US category with traceable assembly.

Stage two: resequence the deck. Slide one names the US design partner, the US ARR figure however modest, and the US TAM. Slide two is the market problem with named US comparables. Slide three is the named US peer set inside the round dynamics. Technology depth moves to slide five or six. Founding team and IP move to the appendix or the technical-deep-dive deck. The first three slides carry the market evidence the US investor scores on.

Stage three: stage the US presence. A US-based founder hire, a US operating lead, or a US specialist bench with named US deeptech veterans creates the fifth scan signal. The hire does not have to be in San Francisco. It has to be visible, named, and operating inside US deeptech conversation. The next US investor meeting hears a different story.

This work fits inside a Market-Entry Marketing Sprint (six to ten weeks, one fundraise, one US category), a Cross-Border Marketing Build (three to six months, full US investor and commercial rebuild), or a Global Marketing Partnership (monthly retainer, twelve-month minimum, for deeptech groups with multiple US-facing programmes). Pricing is discussed privately after GMA knows the work needed.

Before rebuild (EU deeptech narrative)After rebuild (US deeptech narrative)
Slide one: technology architecture and IP positionSlide one: named US design partner, US ARR, US TAM
TAM: top-down global figureTAM: bottom-up build to a named US category with adjacencies
Customer evidence: European pilotsCustomer evidence: named US design partners with paid pilot status
Founding team: European labs and credentialsFounding team + US operating presence with named US specialists
US investor outcome: polite pass after technical meetingUS investor outcome: term sheet conversation inside two cycles
Round shape: EU-onlyRound shape: blended EU-US with US lead in play
Sequence

Market evidence first, deck second, US presence third. Technology depth is a precondition. It is not the round thesis.


Frequently asked.

EU deeptech investors weight technology depth, founding team credentials, and patent strength as load-bearing on first evaluation. US deeptech investors weight market evidence on first evaluation: named US design partners, US-paid pilots, quantified US ARR or revenue line, US peer comparables, and a stated US TAM with bottom-up build. The Munich deck typically opens technology-first and arrives in the US investor's inbox without the market evidence the US buyer scans for. The technology is interesting and the file fails on market signal.

Five things: a named US design partner or paid pilot, a quantified US ARR or revenue line however modest, a stated US TAM with bottom-up build to a US category, a US peer comparable inside the round dynamics, and a US-based founder or operating presence. None of these are about the technology itself. All of them are about market evidence. The US deeptech investor accepts that the technology works as a precondition, not as the round thesis.

A US founder or US operating presence helps with the fifth scan signal. It does not substitute for the first four. A Munich deeptech firm with a US-based founder and no US design partners and no US ARR still fails on the market evidence layer. The hire is a complement to the rebuild, not the rebuild.

Often. Munich deeptech firms typically present a top-down TAM derived from global market sizing. US investors want a bottom-up build to a named US category with named adjacent comparables. A bottom-up US TAM smaller than the top-down global TAM lands as more credible than a large headline number with no traceable assembly. Per Roland Berger deeptech outlook, US deeptech investors explicitly weight bottom-up TAM construction over headline figures.

Inquiry through the contact form and a first fit screening. Share the current US-facing investor deck, the last three US investor passes with feedback if available, the US TAM material, and the US design-partner or pilot pipeline. Response within one business day. Pricing is discussed privately after GMA knows the work needed.

What this work does not include.

No legal services. No US entity formation. No fundraising placement agency function. No SEC, FINRA, or any other regulator registration. No US tax structuring, double-tax-treaty analysis, or transfer pricing. No US banking introductions. No fiduciary services. No IP filing or patent prosecution. No technology development, applied R&D, or scientific consulting. No M&A transaction work. No executive search or hiring. The legal, fundraising, technical, and operational substance sits with counsel, placement agents, technical specialists, and operational consultants on both sides of the corridor. GMA rebuilds the US-facing investor narrative and the website, deck, and sales material that runs alongside it. When a marketing decision touches legal, fundraising, regulatory, or technical implications, GMA flags it and defers before execution.

Check why the buyer is not moving.

If the market is not responding, the first question is simple: what is the buyer not seeing, trusting, or doing yet?

Action that should happenThe buyer should request a quote, ask for a call, send an RFQ, move a proposal forward, or hand the work to the right internal person.
What may be unclearIf that is not happening, the market may not understand the category, proof, offer, price, channel, service answer, or follow-up.
What to inspectCheck the page, sales deck, product proof, offer language, contact path, and follow-up before adding more traffic or more distributors.
Next stepIf the break is commercial, continue to /engagements/ or /contact/#inquiry.

Start the inquiry →

If the US investor took the CTO meeting and passed without a customer call, describe the file.

Share the US deck, the last three pass conversations, and the US design-partner pipeline. Response within one business day.

Start the inquiry
Start the inquiry